Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression : a randomized trial. / Knorr, Ulla; Vinberg, Maj; Mortensen, Erik Lykke; Winkel, Per; Gluud, Christian; Wetterslev, Jørn; Gether, Ulrik; Kessing, Lars Vedel.
In: P L o S One, Vol. 7, No. 2, 29.02.2012, p. e31980.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression
T2 - a randomized trial
AU - Knorr, Ulla
AU - Vinberg, Maj
AU - Mortensen, Erik Lykke
AU - Winkel, Per
AU - Gluud, Christian
AU - Wetterslev, Jørn
AU - Gether, Ulrik
AU - Kessing, Lars Vedel
PY - 2012/2/29
Y1 - 2012/2/29
N2 - The serotonergic neurotransmitter system is closely linked to depression and personality traits. It is not known if selective serotonin reuptake inhibitors (SSRI) have an effect on neuroticism that is independent of their effect on depression. Healthy individuals with a genetic liability for depression represent a group of particular interest when investigating if intervention with SSRIs affects personality. The present trial is the first to test the hypothesis that escitalopram may reduce neuroticism in healthy first-degree relatives of patients with major depressive disorder (MD).
AB - The serotonergic neurotransmitter system is closely linked to depression and personality traits. It is not known if selective serotonin reuptake inhibitors (SSRI) have an effect on neuroticism that is independent of their effect on depression. Healthy individuals with a genetic liability for depression represent a group of particular interest when investigating if intervention with SSRIs affects personality. The present trial is the first to test the hypothesis that escitalopram may reduce neuroticism in healthy first-degree relatives of patients with major depressive disorder (MD).
U2 - 10.1371/journal.pone.0031980
DO - 10.1371/journal.pone.0031980
M3 - Journal article
C2 - 22393376
VL - 7
SP - e31980
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 2
ER -
ID: 38186391